Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma by Bartlett, Nancy L., Assouline, Sarit, Giri, Pratyush, Schuster, Stephen J., Cheah, Chan Yoon, Matasar, Matthew, Gregory, Gareth P., Yoon, Dok Hyun, Shadman, Mazyar, Fay, Keith, Yoon, Sung-Soo, Panizo, Carlos, Flinn, Ian, Johnston, Anna, Bosch, Francesc, Sehn, Laurie H., Wei, Michael C., Yin, Shen, To, Iris, Li, Chi-Chung, Huang, Huang, Kwan, Antonia, Penuel, Elicia, Budde, Lihua E.

Get full text

CT Demonstration of Local Cytokine-Release Syndrome Involving the Head and Neck Following Chimeric Antigen Receptor T Cell Infusion Therapy by Ko, Ji Su, Lee, Jeong Hyun, Yoon, Dok Hyun, Suh, Chong Hyun, Chung, Sae Rom, Choi, Young Jun, Baek, Jung Hwan

Get full text

Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma by Yoo, Changhoon, Yoon, Dok Hyun, Kim, Jeong Eun, Jo, Jungmin, Park, Seong Joon, Yoon, Shin-Kyo, Ahn, Yongchel, Kim, Shin, Huh, Jooryung, Lee, Dae Ho, Suh, Cheolwon

Get full text

A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea by Kook, Hye Won, Jang, Ji Eun, Min, Chang-Ki, Yoon, Dok Hyun, Kim, Kihyun, Bang, Soo-Mee, Park, Yong, Lee, Jae Hoon, Yoon, Sung-Soo, Kim, Jin Seok

Get full text

Incidence of immune effector cell-associated neurotoxicity among patients treated with CAR T-cell therapy for hematologic malignancies: systematic review and meta-analysis by Han, Min Woo, Jeong, So Yeong, Suh, Chong Hyun, Park, Hyesun, Guenette, Jeffrey P, Huang, Raymond Y, Kim, Kyung Won, Yoon, Dok Hyun

Get full text

Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response by Park, Ho Young, Kim, Kyung Won, Yoon, Min A, Lee, Min Hee, Chae, Eun Jin, Lee, Jeong Hyun, Chung, Hye Won, Yoon, Dok Hyun

Get full text

Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results by Rai, Shinya, Kim, Won Seog, Ando, Kiyoshi, Choi, Ilseung, Izutsu, Koji, Tsukamoto, Norifumi, Maruyama, Dai, Tsukasaki, Kunihiro, Kuroda, Junya, Ando, Jun, Hidaka, Michihiro, Koh, Youngil, Kato, Hisashi, Uchida, Toshiki, Yang, Deok Hwan, Ishitsuka, Kenji, Ishizawa, Kenichi, Kim, Jin Seok, Lee, Hong Ghi, Minami, Hironobu, Eom, Hyeon Seok, Kurosawa, Mitsutoshi, Lee, Jae Hoon, Lee, Jong Seok, Lee, Won Sik, Nagai, Hirokazu, Shindo, Takero, Yoon, Dok Hyun, Yoshida, Shinichiro, Gillings, Mireille, Onogi, Hiroshi, Tobinai, Kensei

Get full text

A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffus... by Yoon, Sang Eun, Kim, Seok Jin, Yoon, Dok Hyun, Koh, Youngil, Mun, Yeung-Chul, Do, Young Rok, Choi, Yoon Seok, Yang, Deok Hwan, Kim, Min Kyoung, Lee, Gyeong-Won, Suh, Cheolwon, Ko, Young Hyeh, Kim, Won Seog

Get full text

Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck by Kim, Han Sang, Kwon, Hyeong Ju, Jung, Inkyung, Yun, Mi Ran, Ahn, Myung-Ju, Kang, Byung Woog, Sun, Jong-Mu, Kim, Sung Bae, Yoon, Dok-Hyun, Park, Keon Uk, Lee, Se-Hoon, Koh, Yoon Woo, Kim, Se Hun, Choi, Eun Chang, Koo, Dong Hoe, Sohn, Jin Hee, Kim, Bomi, Kwon, Nak-Jung, Yun, Hwan Jung, Lee, Min Goo, Lee, Ji Hyun, Kim, Tae-Min, Kim, Hye Ryun, Kim, Joo Hang, Paik, Soonmyung, Cho, Byoung Chul

Get full text

Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma by Kim, Seok Jin, Yoon, Dok Hyun, Kang, Hye Jin, Hong, Jung Yong, Lee, Ho Sup, Oh, Sung Yong, Shin, Ho-Jin, Kong, Jee Hyun, Yi, Jun Ho, Sakamoto, Kana, Ko, Young Hyeh, Huh, Jooryung, Lee, Seung-Sook, Takeuchi, Kengo, Shin, Dong-Yeop, Suh, Cheolwon, Kim, Won Seog

Get full text

Assessment of NK Cell Activity Based on NK Cell-Specific Receptor Synergy in Peripheral Blood Mononuclear Cells and Whole Blood by Kim, Jung Min, Yi, Eunbi, Cho, Hyungwoo, Choi, Woo Seon, Ko, Dae-Hyun, Yoon, Dok Hyun, Hwang, Sang-Hyun, Kim, Hun Sik

Get full text

Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805) by Kim, Kihyun, Kim, Jin Seok, Yoon, Sung-Soo, Yoon, Dok Hyun, Eom, Hyeon-Seok, Lee, Je-Jung, Yim, Hyeon Woo, Park, Misun, Lee, Hojoon, Min, Chang-Ki

Get full text

Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study by Kim, Won Seog, Oki, Yasuhiro, Kim, Seok Jin, Yoon, Sang Eun, Ardeshna, Kirit M., Lin, Yi, Ruan, Jia, Porcu, Pierluigi, Brammer, Jonathan E., Jacobsen, Eric D., Yoon, Dok Hyun, Suh, Cheolwon, Suarez, Felipe, Radford, John, Budde, Lihua E., Kim, Jin Seok, Bachy, Emmanuel, Lee, Hun Ju, Bollard, Catherine M., Jaccard, Arnaud, Kang, Hye Jin, Inman, Shannon, Murray, Maryann, Combs, Katherin E., Lee, Daniel Y., Advani, Ranjana, Gunter, Kurt C., Rooney, Cliona M., Heslop, Helen E.

Get full text

A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma by Cho, Jeong-Yeon, Jang, Suk-Chan, Kang, Dong-Won, Lee, Eui-Kyung, Koh, Hyein, Yoon, Dok Hyun, Park, Mi-Hai

Get full text

Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial by Kim, Seok Jin, Yoon, Dok Hyun, Kang, Hye Jin, Kim, Jin Seok, Park, Seong Kyu, Kim, Hyo Jung, Lee, Jeeyun, Ryoo, Baek-Yeol, Ko, Young Hyeh, Huh, Jooryung, Yang, Woo Ick, Kim, Hee Kyung, Min, Soo Kee, Lee, Seung-Sook, Do, In-Gu, Suh, Cheolwon, Kim, Won Seog

Get full text

Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group by Yoon, Dok Hyun, Cao, Junning, Chen, Tsai-Yun, Izutsu, Koji, Kim, Seok Jin, Kwong, Yok Lam, Lin, Tong Yu, Thye, Lim Soon, Xu, Bing, Yang, Deok Hwan, Kim, Won Seog

Get full text

Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma by Chu, Tan-Huy, Jung, Sung-Hoon, Kim, Kihyun, Lee, Jae Hoon, Mun, Yeung-Chul, Bang, Soo-Mee, Yoon, Dok Hyun, Lee, Ho Sup, Min, Chang-Ki, Lee, Je-Jung

Get full text

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation by Kim, Seok Jin, Jo, Jae-Cheol, Yoon, Dok Hyun, Yang, Deok-Hwan, Yoon, Sang Eun, Lee, Gyeong-Won, Kong, Jee Hyun, Park, Yong, Kang, Ka-Won, Lee, Ho-Sup, Oh, Sung Yong, Shin, Ho-Jin, Lee, Won Sik, Choi, Yoon Seok, Jeong, Seong Hyun, Kim, Min Kyoung, Kang, Hye Jin, Yi, Jun Ho, Lim, Sung-Nam, Yhim, Ho-Young, Do, Young Rok, Yun, Hwan Jung, Eom, Hyeon-Seok, Lee, Mark Hong, Suh, Cheolwon, Kim, Won Seog

Get full text

Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2 by Roh, Jin, Cho, Hyungwoo, Yoon, Dok Hyun, Hong, Jung Yong, Lee, A-Neum, Eom, Hyeon Seok, Lee, Hyewon, Park, Weon Seo, Han, Jae Ho, Jeong, Seong Hyun, Park, Joon Seong, Pak, Hyo-Kyung, Kim, So-Woon, Kim, Sang-Yeob, Suh, Cheolwon, Huh, Jooryung, Park, Chan-Sik

Get full text

Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09) by Kang, Sora, Cho, Hyungwoo, Sohn, Byeong Seok, Oh, Sung Yong, Lee, Won-Sik, Lee, Sang Min, Yang, Deok-Hwan, Huh, Jooryung, Yoon, Dok Hyun, Suh, Cheolwon

Get full text